Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1123.00 | 1357.25 | 0.8274 | 0.6898 | |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1286.00 | 1357.25 | 0.9475 | 0.9063 | |
| BT-20 | Linsitinib | 1 | uM | 8 | 1250.00 | 622.75 | 1300.00 | 1357.25 | 0.9578 | 0.9248 |
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 1250.00 | 622.75 | 1274.00 | 1357.25 | 0.9387 | 0.8905 |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1428.00 | 1357.25 | 1.0521 | 1.0925 | |
| BT-20 | Linsitinib | 19.9526 | uM | 8 | 1250.00 | 622.75 | 1113.00 | 1357.25 | 0.8200 | 0.6764 |
| BT-20 | Linsitinib | 0.0033113 | uM | 8 | 1250.00 | 622.75 | 1652.00 | 1357.25 | 1.2172 | 1.3821 |
| BT-20 | Erlotinib | 10 | uM | 8 | 1250.00 | 622.75 | 1332.00 | 1357.25 | 0.9814 | 0.9669 |
| BT-20 | Erlotinib | 3.1623 | uM | 8 | 1250.00 | 622.75 | 1591.00 | 1357.25 | 1.1722 | 1.3037 |
| BT-20 | 17-AAG | 0.0031623 | uM | 8 | 1250.00 | 622.75 | 1850.00 | 1357.25 | 1.3631 | 1.6346 |
| BT-20 | Erlotinib | 0.01 | uM | 8 | 1250.00 | 622.75 | 2025.00 | 1357.25 | 1.4920 | 1.8552 |
| BT-20 | Linsitinib | 0.01 | uM | 8 | 1250.00 | 622.75 | 1704.00 | 1357.25 | 1.2555 | 1.4487 |
| BT-20 | 17-AAG | 0.0001 | uM | 8 | 1250.00 | 622.75 | 1785.00 | 1357.25 | 1.3152 | 1.5520 |
| BT-20 | 17-AAG | 0.01 | uM | 8 | 1250.00 | 622.75 | 718.00 | 1357.25 | 0.5290 | 0.1350 |
| BT-20 | Linsitinib | 10 | uM | 8 | 1250.00 | 622.75 | 1444.00 | 1357.25 | 1.0639 | 1.1133 |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1775.00 | 1357.25 | 1.3078 | 1.5393 | |
| BT-20 | Lapatinib | 1 | uM | 8 | 1250.00 | 622.75 | 1465.00 | 1357.25 | 1.0794 | 1.1407 |
| BT-20 | Lapatinib | 10 | uM | 8 | 1250.00 | 622.75 | 566.00 | 1357.25 | 0.4170 | -0.0815 |
| BT-20 | Lapatinib | 0.0033113 | uM | 8 | 1250.00 | 622.75 | 1603.00 | 1357.25 | 1.1811 | 1.3192 |
| BT-20 | Linsitinib | 0.1 | uM | 8 | 1250.00 | 622.75 | 1580.00 | 1357.25 | 1.1641 | 1.2895 |
| BT-20 | Lapatinib | 0.031623 | uM | 8 | 1250.00 | 622.75 | 1656.00 | 1357.25 | 1.2201 | 1.3873 |
| BT-20 | 17-AAG | 0.031623 | uM | 8 | 1250.00 | 622.75 | 513.00 | 1357.25 | 0.3780 | -0.1584 |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1165.00 | 1357.25 | 0.8584 | 0.7459 | |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1144.00 | 1357.25 | 0.8429 | 0.7178 | |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 2663.00 | 3547.00 | 0.7508 | 0.6296 |